Manganese-Enhanced Magnetic Resonance Imaging in Takotsubo Syndrome

Trisha Singh, Shruti Joshi, Lucy E Kershaw, Andy H Baker, Gerry P McCann, Dana K Dawson, Marc R Dweck, Scott I Semple, David E Newby, Trisha Singh, Shruti Joshi, Lucy E Kershaw, Andy H Baker, Gerry P McCann, Dana K Dawson, Marc R Dweck, Scott I Semple, David E Newby

Abstract

Background: Takotsubo syndrome is an acute cardiac emergency characterized by transient left ventricular systolic dysfunction typically following a stressful event. Despite its rapidly rising incidence, its pathophysiology remains poorly understood. Takotsubo syndrome may pass unrecognized, especially if timely diagnostic imaging is not performed. Defective myocardial calcium homeostasis is a central cause of contractile dysfunction and has not been explored in takotsubo syndrome. We aimed to investigate myocardial calcium handling using manganese-enhanced magnetic resonance imaging during the acute and recovery phases of takotsubo syndrome.

Methods: Twenty patients with takotsubo syndrome (63±12 years of age; 90% female) and 20 volunteers matched on age, sex, and cardiovascular risk factors (59±11 years of age; 70% female) were recruited from the Edinburgh Heart Centre between March 2020 and October 2021. Patients underwent gadolinium and manganese-enhanced magnetic resonance imaging during index hospitalization with repeat manganese-enhanced magnetic resonance imaging performed after at least 3 months.

Results: Compared with matched control volunteers, patients had a reduced left ventricular ejection fraction (51±11 versus 67±8%; P<0.001), increased left ventricular mass (86±11 versus 57±14 g/m2; P<0.001), and, in affected myocardial segments, elevated native T1 (1358±49 versus 1211±28 ms; P<0.001) and T2 (60±7 versus 38±3 ms; P<0.0001) values at their index presentation. During manganese-enhanced imaging, kinetic modeling demonstrated a substantial reduction in myocardial manganese uptake (5.1±0.5 versus 8.2±1.1 mL/[100 g of tissue ·min], respectively; P<0.0001), consistent with markedly abnormal myocardial calcium handling. After recovery, left ejection fraction, left ventricular mass, and T2 values were comparable with those of matched control volunteers. Despite this, native and postmanganese T1 and myocardial manganese uptake remained abnormal compared with matched control volunteers (6.6±0.5 versus 8.2±1.1 mL/[100 g of tissue ·min]; P<0.0001).

Conclusions: In patients with takotsubo syndrome, there is a profound perturbation of myocardial manganese uptake, which is most marked in the acute phase but persists for at least 3 months despite apparent restoration of normal left ventricular ejection fraction and resolution of myocardial edema, suggesting abnormal myocardial calcium handling may be implicated in the pathophysiology of takotsubo syndrome. Manganese-enhanced magnetic resonance imaging has major potential to assist in the diagnosis, characterization, and risk stratification of patients with takotsubo syndrome.

Registration: URL: https://www.

Clinicaltrials: gov; Unique identifier: NCT04623788.

Keywords: calcium; magnetic resonance imaging; manganese; takotsubo cardiomyopathy.

Conflict of interest statement

CONFLICTS OF INTEREST DISCOLSURES

DEN and SIS hold unrestricted educational grants from Siemens Healthineers. GPM holds a research agreement with Circle CVi through University Hospitals of Leicester NHS Trust.

Figures

Figure 1. Consort Diagram
Figure 1. Consort Diagram
Figure 2. Anatomical Types of Takotsubo Syndrome
Figure 2. Anatomical Types of Takotsubo Syndrome
Short-axis and long-axis manganese-enhanced T1 maps and long-axis late-gadolinium images (10 min post contrast) in a matched control volunteer (panel A), and patients with apical (panel B), basal (panel C) and focal (panel D) takotsubo syndrome. Blue represents normal manganese uptake and green represents reduced manganese uptake and abnormal calcium handling.
Figure 3. Myocardial Edema and Left Ventricular…
Figure 3. Myocardial Edema and Left Ventricular Mass in Takotsubo Syndrome
Changes in left ventricular mass (panel A), native T2 (panel B), native T1 (panel C) and 30 min post manganese T1 maps (panel D). Correlations are seen between left ventricular mass and native T2 (E), left ventricular wall thickness and native T2 (F), myocardial manganese uptake and left ventricular mass (G) and myocardial manganese uptake and native T2 (H) during acute (red) and follow up (blue) scans.
Figure 4. Gadolinium Enhancement in Patients with…
Figure 4. Gadolinium Enhancement in Patients with Takotsubo Syndrome
Short-axis views of inferior late-gadolinium enhancement in a patient with spontaneous coronary artery dissection of the obtuse marginal branch of the left circumflex artery (A) and apical takotsubo (dual pathology). During acute imaging reduced myocardial manganese uptake (green) extends beyond the infarct region (B). Follow-up imaging demonstrates recovery of manganese uptake (blue) in regions affected by takotsubo syndrome with persistent abnormal manganese uptake (green) in the infarct region (C). Long-axis, four chamber view demonstrating characteristic hazy “incomplete nulling” in late-gadolinium enhancement imaging in a patient with apical takotsubo (D). Corresponding native T1 map during acute event demonstrates elevated native T1 in mid-ventricle and apical segments (E), with resolution on follow-up scans (F).
Figure 5. Manganese-enhanced Magnetic Resonance Imaging in…
Figure 5. Manganese-enhanced Magnetic Resonance Imaging in Takotsubo Syndrome
Resolution of left ventricular systolic dysfunction (A) and apical ballooning (B and C) in a patient with takotsubo syndrome scanned 18 days after symptom onset. Long-axis (D) and short-axis (E) manganese-enhanced T1 map demonstrating typical apical pattern of takotsubo syndrome with abnormal myocardial manganese uptake (green) in mid-ventricular and apical segments with normal uptake (blue) in basal segments despite apparent restoration of normal cardiac function.
Figure 6. Myocardial Calcium Handling in Takotsubo…
Figure 6. Myocardial Calcium Handling in Takotsubo Syndrome
Short-axis and long-axis manganese-enhanced T1 map in a (panel A) matched control volunteer and (panel B) patient with acute takotsubo syndrome demonstrating reduced manganese uptake (green). Short-axis and long-axis manganese-enhanced T1 maps at follow-up (panel C) demonstrating improvement (patchy) myocardial manganese uptake (as calculated by Patlak modelling) but persistent abnormalities compared to matched control volunteers (D).

References

    1. Ghadri JR, Wittstein IS, Prasad A, Sharkey S, Dote K, Akashi YJ, Cammann VL, Crea F, Galiuto L, Desmet W, et al. International expert consensus document on takotsubo syndrome (part i): Clinical characteristics,diagnostic criteria, and pathophysiology. Eur Heart J. 2018;39:2032–2046.
    1. Sato TH, Uchida T, Dote KMI. Tako-tsubo-like left ventricular dysfunction due to multivessel coronary spasm. Clinical Aspect of Myocardial Injury: From Ischemia to Heart Failure. Kagakuhyoronsha Publishing Co; Tokyo,Japan: 1990.
    1. Akashi YJ, Goldstein DS, Barbaro G, Ueyama T. Takotsubo cardiomyopathy: A new form of acute, reversible heart failure. Circulation. 2008;118:2754–2762.
    1. Kurisu S, Sato H, Kawagoe T, Ishihara M, Shimatani Y, Nishioka K, Kono Y, Umemura T, Nakamura S. Tako-tsubo-like left ventricular dysfunction with st-segment elevation: A novel cardiac syndrome mimicking acute myocardial infarction. Am Heart J. 2002;143:448–455.
    1. Citro R, Okura H, Ghadri JR, Izumi C, Meimoun P, Izumo M, Dawson D, Kaji S, Eitel I, Kagiyama N, et al. Multimodality imaging in takotsubo syndrome: A joint consensus document of the european association of cardiovascular imaging (eacvi) and the japanese society of echocardiography (jse) J Echocardiogr. 2020;18:199–224.
    1. Scally C, Abbas H, Ahearn T, Srinivasan J, Mezincescu A, Rudd A, Spath N, Yucel-Finn A, Yuecel R, Oldroyd K, et al. Myocardial and systemic inflammation in acute stress- induced (takotsubo) cardiomyopathy. Circulation. 2019;139:1581–1592.
    1. Hunter DR, Haworth RA, Berkoff HA. Cellular manganese uptake by the isolated perfused rat heart: A probe for the sarcolemma calcium channel. J Mol Cell Cardiol. 1981;13:823–832.
    1. Spath NB, Singh T, Papanastasiou G, Baker A, Janiczek RJ, McCann GP, Dweck MR, Kershaw L, Newby DE, Semple S. Assessment of stunned and viable myocardium using manganese-enhanced mri. Open Heart. 2021:8.
    1. Spath NB, Singh T, Papanastasiou G, Kershaw L, Baker AH, Janiczek RL, Gulsin GS, Dweck MR, McCann G, Newby DE, et al. Manganese-enhanced magnetic resonance imaging in dilated cardiomyopathy and hypertrophic cardiomyopathy. Eur Heart J Cardiovasc Imaging. 2020
    1. Abe Y, Kondo M, Matsuoka R, Araki M, Dohyama K, Tanio H. Assessment of clinical features in transient left ventricular apical ballooning. J Am Coll Cardiol. 2003;41:737–742.
    1. Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D, Moss AJ, Seidman CE, Young JB, American Heart A, et al. Contemporary definitions and classification of the cardiomyopathies: An american heart association scientific statement from the council on clinical cardiology, heart failure and transplantation committee; quality of care and outcomes research and functional genomics and translational biology interdisciplinary working groups; and council on epidemiology and prevention. Circulation. 2006;113:1807–1816.
    1. Singh T, Kite TA, Joshi SS, Spath NB, Kershaw L, Baker A, Jordan H, Gulsin GS, Williams MC, van Beek EJR, et al. Mri and ct coronary angiography in survivors of covid-19 Heart. 2021
    1. Spath N, Tavares A, Gray GA, Baker AH, Lennen RJ, Alcaide-Corral CJ, Dweck MR, Newby DE, Yang PC, Jansen MA, et al. Manganese-enhanced t1 mapping to quantify myocardial viability: Validation with (18)f-fluorodeoxyglucose positron emission tomography. Sci Rep. 2020;10:2018.
    1. Patlak CS, Blasberg RG, Fenstermacher JD. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab. 1983;3:1–7.
    1. Skjold A, Kristoffersen A, Vangberg TR, Haraldseth O, Jynge P, Larsson HB. An apparent unidirectional influx constant for manganese as a measure of myocardial calcium channel activity. J Magn Reson Imaging. 2006;24:1047–1055.
    1. Singh T, Khan H, Gamble DT, Scally C, Newby DE, Dawson D. Takotsubo syndrome: Pathophysiology, emerging concepts, and clinical implications. Circulation. 2022;145:1002–1019.
    1. El-Battrawy I, Gietzen T, Ansari U, Behnes M, Lang S, Zhou X, Borggrefe M, Akin I. Short-term and long-term incidence of stroke in takotsubo syndrome. ESC Heart Fail. 2018;5:1191–1194.
    1. El-Battrawy I, Gietzen T, Lang S, Ansari U, Behnes M, Zhou X, Borggrefe M, Akin I. Short- and long-term incidence of thromboembolic events in takotsubo syndrome as compared with acute coronary syndrome. Angiology. 2019;70:838–843.
    1. Ghadri JR, Kato K, Cammann VL, Gili S, Jurisic S, Di Vece D, Candreva A, Ding KJ, Micek J, Szawan KA, et al. Long-term prognosis of patients with takotsubo syndrome. J Am Coll Cardiol. 2018;72:874–882.
    1. Nef HM, Mollmann H, Troidl C, Kostin S, Voss S, Hilpert P, Behrens CB, Rolf A, Rixe J, Weber M, et al. Abnormalities in intracellular ca2+ regulation contribute to the pathomechanism of tako-tsubo cardiomyopathy. Eur Heart J. 2009;30:2155–2164.
    1. Scally C, Rudd A, Mezincescu A, Wilson H, Srivanasan J, Horgan G, Broadhurst P, Newby DE, Henning A, Dawson DK. Persistent long-term structural, functional, and metabolic changes after stress-induced (takotsubo) cardiomyopathy. Circulation. 2018;137:1039–1048.
    1. Di Vece D, Citro R, Cammann VL, Kato K, Gili S, Szawan KA, Micek J, Jurisic S, Ding KJ, Bacchi B, et al. Outcomes associated with cardiogenic shock in takotsubo syndrome. Circulation. 2019;139:413–415.
    1. Redfors B, Jha S, Thorleifsson S, Jernberg T, Angeras O, Frobert O, Petursson P, Tornvall P, Sarno G, Ekenback C, et al. Short- and long-term clinical outcomes for patients with takotsubo syndrome and patients with myocardial infarction: A report from the swedish coronary angiography and angioplasty registry. J Am Heart Assoc. 2021;10:e017290.
    1. Templin C, Ghadri JR, Diekmann J, Napp LC, Bataiosu DR, Jaguszewski M, Cammann VL, Sarcon A, Geyer V, Neumann CA, et al. Clinical features and outcomes of takotsubo (stress) cardiomyopathy. N Engl J Med. 2015;373:929–938.
    1. Uribarri A, Nunez-Gil IJ, Conty DA, Vedia O, Almendro-Delia M, Duran Cambra A, Martin-Garcia AC, Barrionuevo-Sanchez M, Martinez-Selles M, Raposeiras-Roubin S, et al. Short- and long-term prognosis of patients with takotsubo syndrome based on different triggers: Importance of the physical nature. J Am Heart Assoc. 2019;8:e013701.
    1. Jynge P, Brurok H, Asplund A, Towart R, Refsum H, Karlsson JO. Cardiovascular safety of mndpdp and mncl2. Acta Radiol. 1997;38:740–749.
    1. Marti-Bonmati L, Fog AF, de Beeck BO, Kane P, Fagertun H. Safety and efficacy of mangafodipir trisodium in patients with liver lesions and cirrhosis. Eur Radiol. 2003;13:1685–1692.
    1. Kume T, Akasaka T, Kawamoto T, Yoshitani H, Watanabe N, Neishi Y, Wada N, Yoshida K. Assessment of coronary microcirculation in patients with takotsubo-like left ventricular dysfunction. Circulation Journal. 2005;69:934–939.
    1. Bybee KA, Murphy J, Prasad A, Wright RS, Lerman A, Rihal CS, Chareonthaitawee P. Acute impairment of regional myocardial glucose uptake in the apical ballooning (takotsubo) syndrome. J Nucl Cardiol. 2006;13:244–250.

Source: PubMed

3
Abonnere